Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-12

Clinical Trial Update: Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial of denileukin diftitox followed by vaccine therapy in patients with metastatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Denileukin diftitox (denileukin diftitox)
  • Vaccine therapy

Snippet

Sponsor: H. Kim Lyerly | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED